Position in VTRS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$281,075
+$56,593 QoQ
Shares Held
17,700
+6.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#494
of 1,016 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026HUNTINGTON NATIONAL BANK holds $8,942,562 across 35 Drug Manufacturers - Specialty & Generic names. VTRS ranks #3 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
78,405 | $5,634,180 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
4,164 | $2,256,179 | |
| 3 | VTRS |
Viatris Inc
This page
|
17,700 | $281,075 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
8,001 | $271,073 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
763 | $128,596 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
|
2,200 | $103,994 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
8,129 | $81,290 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
1,402 | $34,503 |
All Filings in VTRS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $281,075 | 17,700 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $224,482 | 16,616 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $207,889 | 16,698 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $172,042 | 17,378 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $162,552 | 18,203 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $104,415 | 11,988 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $218,683 | 17,565 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $164,222 | 14,145 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $155,208 | 14,601 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $198,442 | 16,620 | Shares | Defined | 2024-05-03 | |
| 2023-12-31 | $233,504 | 21,561 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $239,518 | 24,292 | Shares | Defined | 2023-11-08 | |
| 2023-06-30 | $271,026 | 27,157 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $262,817 | 27,320 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $320,264 | 28,775 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $296,734 | 34,828 | Shares | Defined | 2022-11-07 | |
| 2022-06-30 | $403,366 | 38,526 | Shares | Defined | 2022-08-09 | |
| 2022-03-31 | $457,438 | 42,044 | Shares | Defined | 2022-05-10 | |
| 2021-12-31 | $656,420 | 48,516 | Shares | Defined | 2022-01-21 | |
| 2021-09-30 | $713,162 | 52,632 | Shares | Defined | 2021-10-28 | |
| 2021-06-30 | $793,509 | 55,529 | Shares | Defined | 2021-07-30 | |
| 2021-03-31 | $960,003 | 68,719 | Shares | Defined | 2021-04-12 | |
| 2020-12-31 | $1,739,632 | 92,830 | Shares | Defined | 2021-01-11 | |
| No filing history on record for this holder in this stock. | ||||||